GUGGENHEIM CAPITAL LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 121 filers reported holding CARA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$99,000
-54.8%
10,598
-56.0%
0.00%
-50.0%
Q2 2022$219,000
+51.0%
24,086
+100.7%
0.00%
+100.0%
Q1 2022$145,000
-3.3%
11,999
-2.6%
0.00%0.0%
Q4 2021$150,000
-89.9%
12,324
-88.7%
0.00%
-75.0%
Q3 2017$1,491,000108,9580.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Chescapmanager LLC 1,655,576$4,685,2800.73%
Bain Capital Life Sciences Investors, LLC 934,898$2,645,7610.27%
FNY Investment Advisers, LLC 35,000$990.12%
DISCIPLINED GROWTH INVESTORS INC /MN 1,764,201$4,992,6890.11%
Ergoteles LLC 358,275$1,013,9180.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$239,2200.04%
PDT Partners, LLC 85,088$240,7990.03%
PINNACLE ASSOCIATES LTD 672,440$1,903,0050.03%
Alpine Global Management, LLC 34,014$96,2600.03%
XTX Topco Ltd 52,025$147,2310.03%
View complete list of CARA THERAPEUTICS INC shareholders